Literature DB >> 18063364

Design and optimization of imidazole derivatives as potent CXCR3 antagonists.

Xiaohui Du1, Xiaoqi Chen, Jeffrey T Mihalic, Jeffrey Deignan, Jason Duquette, An-Rong Li, Bryan Lemon, Ji Ma, Shichang Miao, Karen Ebsworth, Timothy J Sullivan, George Tonn, Tassie L Collins, Julio C Medina.   

Abstract

A series of imidazole derivatives have been designed and optimized for CXCR3 antagonism, pharmacokinetic properties, and reduced formation of glutathione conjugates. Our efforts led to the discovery of potent CXCR3 antagonists with good pharmacokinetic properties. These compounds are useful tools for in vivo studies of CXCR3 function.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18063364     DOI: 10.1016/j.bmcl.2007.11.072

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

1.  A combined LS-SVM & MLR QSAR workflow for predicting the inhibition of CXCR3 receptor by quinazolinone analogs.

Authors:  Antreas Afantitis; Georgia Melagraki; Haralambos Sarimveis; Panayiotis A Koutentis; Olga Igglessi-Markopoulou; George Kollias
Journal:  Mol Divers       Date:  2009-05-30       Impact factor: 2.943

2.  Enantioselective N-heterocyclic carbene catalyzed annulation reactions with imidazolidinones.

Authors:  Elizabeth O'Bryan McCusker; Karl A Scheidt
Journal:  Angew Chem Int Ed Engl       Date:  2013-11-18       Impact factor: 15.336

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.